News
Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, today announced an expanded ...
2don MSN
Baron Funds, an investment management company, released its “Baron Health Care Fund” second-quarter 2025 investor letter. A ...
1d
GlobalData on MSNExact Sciences expands partnership with Humana to improve colorectal cancer screeningThe Cologuard Plus test is being offered as an in-network service to eligible Humana Medicare Advantage members.
Easy at-home tests for colon cancer, including FIT and Cologuard, offer alternatives to traditional colonoscopies for early ...
Researchers found all methods reduced CRC incidence and mortality. In an unscreened population, Cologuard added 82 life years per every 1,000 simulated screening. In that same population, Cologuard ...
Colorectal Cancer Awareness Month is observed annually in March and aims to promote screening and early detection, raise awareness, and offer support to those battling the disease. As it has done ...
Q: What are the screening guidelines recommended for Cologuard?KC: Presently, only the American College of Gastroenterology has a recommended interval for stool DNA testing, which is three years.The U ...
Then, a few months ago, Meaney was watching "Squawk Box," a morning news and talk show, when he heard about Cologuard, an at-home, stool-based test for colorectal cancer, which the Food and Drug ...
Next-generation Cologuard exhibited improved colorectal cancer specificity and sensitivity compared with results of the FDA registrational trial that led to approval of the noninvasive screening ...
Cologuard measures DNA methylation in two genes: NDRG4 and BMP3. Abnormal methylation of NDRG4 and BMP3, considered tumor suppressors, has been linked to colorectal tumors.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results